Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-29 @ 10:59 AM
Study NCT ID:
NCT07135466
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-22
First Post:
2025-07-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor in Patients With CD22 B-cell Malignancies
Sponsor:
Sheba Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-02
First Submit QC Date:
None
Study First Post Date:
2025-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-13
Last Update Post Date:
2025-08-22
Last Update Post Date Type:
ACTUAL